25 C
New York
Monday, June 24, 2024

MDMA’s federal approval drama, briefly explained

MDMA’s federal approval drama, briefly explained

MDMA looked like it was on a fast track for PTSD treatment. Now, an FDA committee is advising otherwise.

By Oshan Jarow, Vox

Today, an Federal Drug Administration advisory committee held a public hearing to weigh the evidence on MDMA therapy for post-traumatic stress disorder, casting a non-binding vote against approving the treatment — indicating strong odds that the FDA will follow suit in their official determination, and setting a handful of precedents for efforts to legalize other psychedelics that are close behind.

More here >

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,045FansLike
396,312FollowersFollow
2,300SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x